Disclosures for "Semaglutide Concentration in Cerebrospinal Fluid from Patients with Early Alzheimer’s Disease After 12 Weeks of Subcutaneous Treatment"
-
Dr. Alford has received personal compensation for serving as an employee of Novo Nordisk, Inc.. Dr. Alford has stock in Novo Nordisk.
-
Dr. Johannsen has received personal compensation for serving as an employee of Novo Nordisk. Dr. Johannsen has or had stock in Novo Nordisk.
-
Marie Bentsen has received personal compensation for serving as an employee of Novo Nordisk.
-
Dr. Belmont-Rausch has received personal compensation for serving as an employee of Novo Nordisk A/S. Dr. Belmont-Rausch has or had stock in Novo Nordisk.Dr. Belmont-Rausch has or had stock in Viking Therapeutics.Dr. Belmont-Rausch has or had stock in Madrigal Pharmaceuticals.
-
Ms. Carstensen has received personal compensation for serving as an employee of Novo Nordisk A/S. Ms. Carstensen has stock in Novo Nordisk A/S.
-
Dr. Jeppesen has received personal compensation for serving as an employee of Novo Nordisk. Dr. Jeppesen has stock in Novo Nordisk.
-
Dr. Martino has received personal compensation for serving as an employee of Novo Nordisk A/S. Dr. Martino has stock in Novo Nordisk. Dr. Martino has stock in Roche. Dr. Martino has stock in Eli Lilly.
-
Marti Jimenez Mausbach has received personal compensation for serving as an employee of Novo Nordisk. Marti Jimenez Mausbach has stock in Novo Nordisk.
-
Dr. Knudsen has stock in Novo Nordisk. Dr. Knudsen has received intellectual property interests from a discovery or technology relating to health care.